Home monitoring of eye pressure compared to hospital monitoring
Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?
This study tests whether using a home device to check eye pressure can help glaucoma patients catch pressure spikes better than regular hospital visits.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Luzerner Kantonsspital Academic / other |
| Locations | 1 site (Lucerne) |
| Trial ID | NCT04485897 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of self-monitoring intraocular pressure at home using the icare HOME device compared to traditional hospital-based diurnal monitoring. It aims to determine if home measurements can better detect pressure peaks in glaucoma patients, which are often missed during standard office visits. Participants will include both glaucoma patients and healthy controls, and they will be required to meet specific eligibility criteria to ensure accurate results. The study seeks to provide insights into the feasibility and reliability of self-tonometry for managing glaucoma.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a diagnosis of glaucoma or healthy controls who meet the study's eligibility criteria.
Not a fit: Patients with conditions that interfere with self-tonometry, such as severe visual impairment or physical disabilities, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower patients to monitor their intraocular pressure more effectively, potentially leading to better management of glaucoma.
How similar studies have performed: Previous studies have shown promise in self-monitoring approaches for chronic conditions, suggesting potential success for this novel application in glaucoma management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed consent * Subjects aged 18 and older * Glaucoma patients and healthy controls * Best corrected visual acuity \>0.1 * Astigmatism ≤ 3dpt. * Good compliance * Central corneal thickness (400-650μm) * Passed certification procedure (detailed description under: Measurements and procedures) * Therapeutic regimen unchanged throughout the past 30 days Exclusion Criteria: * History of ocular trauma * Corneal condition interfering with tonometry (keratoconus, corneal scaring) Visual acuity \<0.1 * Physical or mental disability interfering with self-tonometry (e.g. arthritis, Parkinson's disease) * Dry eye disease * Known or suspected non-compliance, drug or alcohol abuse * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant * Pregnancy * Breastfeeding
Where this trial is running
Lucerne
- Cantonal Hospital of Lucerne — Lucerne, Switzerland (Recruiting)
Study contacts
- Study coordinator: Raphael Fritsche, MD
- Email: raphael.fritsche@luks.ch
- Phone: 0041 205 33 76
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.